Get started
BIOGEN INCBIOGEN INCBIOGEN INC

BIOGEN INC

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Forecast Seasonals Bonds

BIIB trade ideas

BIIB LongBIIB got oversold due to the unsatisfactory results of their Alzheimer studies . This catalyst gives investors opportunity to buy the equity at a discount from it usual value. In addition, BIIB beats their Q1 2019 earnings ( $6.98 EPS vs expectation of $6.87) and the market does not react positively, creating furthemrore a buying opportunity. If we compare the financial ratios of the peers in the same sector , BIIB is clearly at discount of the sectors average and has a strong upside.
NASDAQ:BIIBLong
by Vasyl_U
Biogen Inc: Rare Long-Term Buy Opportunity.Biogen has lost over 30% of its value this month. Looking at the monthly chart, we have concluded that this is a rare investment opportunity as the current price is just above its 1M Support Zone. Historically we see that such an aggressive sell off recently took place in 2015 - 2016 and again the stock managed to recover almost reaching the 390 Resistance again. This pattern may be similar to the one the long term (~10 year) consolidation that took place after the 2000 peak. The price then traded sideways roughly within 17.00 - 71.00, providing a buy opportunity on every major pull back. We believe such an opportunity is presented now. Every dip near the 180 - 205 Support Zone can be bought with 350 - 390 as the Target Zone. ** If you like our free content follow our profile (www.tradingview.com) to get more daily ideas. ** Comments and likes are greatly appreciated.
NASDAQ:BIIBLong
by InvestingScope
1
The Stock Market is a Very Risky PlaceImagine a 63 Billion, that's a B as in Billion Market Cap stock losing 29 % of it's market value, in one single trading day. It happened today to Biogen, the biotec stock darling, when the company withdrew further reasearch on it's highly touted Alzheimer's drug, that was it's main drug in it's reserach and develpoment pipeline. Line Break/ Chart shows the stock plunging thru all chart support in a single day executing on a Head and Shoulder's Pattern that had been building for months. As I have often said, the stock market is a much more risky place than most would even imagine. In Biogen today, big money, and I mean big money, simply did not see this coming. BIIG Last 226.88 THE_UNWIND 3/21/19 Mountains/New York
NASDAQ:BIIBShort
by The_Unwind
6